PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,772.50
Bid: 1,772.00
Ask: 1,772.50
Change: -11.00 (-0.62%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Liberum Downgrades GlaxoSmithKline To Sell

Wed, 30th Jul 2014 09:03

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
SOCGEN CUTS NEXT PRICE TARGET TO 6737 (6820) PENCE - 'HOLD'
----------
TRADERS: NOMURA RAISES AB FOODS PRICE TARGET TO 2480 (2400) PENCE - 'REDUCE'
----------
BERENBERG RAISES REED ELSEVIER PRICE TARGET TO 960 (930) PENCE - 'HOLD'
----------
MORGAN STANLEY CUTS SAINSBURY TO 'EQUAL-WEIGHT' ('OVERWEIGHT')
----------
SOCGEN RAISES BP PRICE TARGET TO 550 (540) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS ROYAL MAIL PRICE TARGET TO 400 (486) PENCE - 'HOLD'
----------
LIBERUM CUTS GLAXOSMITHKLINE TO 'SELL' ('HOLD') - TARGET 1350 (1500) PENCE
----------
HSBC CUTS NEXT TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 7350 PENCE
----------
UBS RAISES RECKITT BENCKISER PRICE TARGET TO 4550 (4450) PENCE - 'SELL'
----------
JPMORGAN RAISES GKN PRICE TARGET TO 460 (430) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK CUTS ST JAMES'S PLACE PRICE TARGET TO 925 (950) PENCE - 'BUY'
----------
JPMORGAN RAISES ST JAMES'S PLACE PRICE TARGET TO 924 (909) PENCE - 'OVERWEIGHT'
----------
CREDIT SUISSE RAISES SMITH & NEPHEW PRICE TARGET TO 890 (865) PENCE - 'NEUTRAL'
----------
NUMIS RAISES STANDARD CHARTERED TO 'ADD' ('HOLD') - TARGET 1400 (1340) PENCE
----------
CANACCORD RAISES BRITISH AMERICAN TOBACCO PRICE TARGET TO 2925 (2900) PENCE - 'SELL'
----------
FTSE 250
----------
HSBC INITIATES PHOENIX GROUP WITH 'OVERWEIGHT' - TARGET 825 PENCE
----------
BERENBERG CUTS THOMAS COOK PRICE TARGET TO 170 (200) PENCE - 'BUY'
----------
TRADERS: NOMURA CUTS BETFAIR TO 'REDUCE' ('NEUTRAL')
----------
LIBERUM CUTS PACE PLC PRICE TARGET TO 390 (420) PENCE - 'HOLD'
----------
JEFFERIES CUTS PACE PLC PRICE TARGET TO 425 (467) PENCE - 'BUY'
----------
BARCLAYS RAISES ELEMENTIS PRICE TARGET TO 246 (243) PENCE - 'UNDERWEIGHT'
----------
SOCGEN CUTS TULLETT PREBON PRICE TARGET TO 245 (305) PENCE - 'HOLD'
----------
HSBC RAISES TULLETT PREBON TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 311 PENCE
----------
BARCLAYS CUTS TULLETT PREBON PRICE TARGET TO 265 (335) PENCE - 'EQUAL WEIGHT'
----------
UBS REMOVES TULLETT PREBON FROM 'LEAST PREFERRED LIST' DIVERSIFIED FINANCIAL
----------
UBS RAISES TULLETT PREBON TO 'NEUTRAL' ('SELL') - TARGET 250 (230) PENCE
----------
DEUTSCHE BANK RAISES RENTOKIL INITIAL PRICE TARGET TO 114 (109) PENCE - 'HOLD'
----------
NUMIS CUTS INFORMA PRICE TARGET TO 620 (645) PENCE - 'BUY'
----------
UBS CUTS INFORMA PRICE TARGET TO 500 (520) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS INFORMA PRICE TARGET TO 520 (530) PENCE - 'HOLD'
----------
HSBC RAISES GREAT PORTLAND PRICE TARGET TO 737 (715) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES DIRECT LINE PRICE TARGET TO 270 (228) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS TATE & LYLE PRICE TARGET TO 685 (715) PENCE - 'HOLD'
----------
NUMIS CUTS HISCOX TO 'HOLD' ('ADD') - TARGET 710 (785) PENCE
----------
NUMIS RAISES RIGHTMOVE PRICE TARGET TO 3397 (3360) PENCE - 'BUY'
----------
CANACCORD CUTS JLT GROUP TO 'HOLD' ('BUY') - TARGET 1070 (1165) PENCE
----------
MAIN MARKET AND AIM
----------
JPMORGAN RAISES GEM DIAMONDS PRICE TARGET TO 235 (200) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.


More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.